- Home
- COVID-19
COVID-19
Caring on the COVID-19 front lines: “I rallied colleagues all over the world to help me make over 2,100 cloth masks”
When Melissa Surdez received an urgent call from her physician sister who was battling the pandemic on the front lines in New Jersey and facing a mask shortage, she promised to help—and tapped Johnson & Johnson’s thousands of employees to join her cause.
“I’m racing to screen thousands of molecules": These scientists are canvassing a vast library in search of a potential COVID-19 treatment
Johnson & Johnson has an expansive archive of existing drug compounds—and two researchers are leading the charge in combing through this molecular storehouse in pursuit of a possible breakthrough.
JLABS @ Washington, DC: The unique innovation hub that’s poised to help protect us from future pandemics
Scientists at the facility, opening in the nation’s capital this year, will be focused on advancing breakthrough ideas for safeguarding people around the world from pandemics like COVID-19, infectious diseases and other health threats.
Chairman and CEO Alex Gorsky profiled by the Financial Times about Johnson & Johnson’s work on a potential COVID-19 vaccine
The article explores what guided the decision, which is just the latest example of our Chairman and CEO’s people-first approach to leadership at our healthcare company.
“I’m a scientist working on a potential COVID-19 vaccine”: Meet a researcher who’s studying a promising candidate
Roland Zahn, Ph.D., a Janssen scientist and expert in viral vaccines, was at the front lines of research during the Ebola outbreak. Today he and his team are working at record speed to help deliver a potential vaccine for the novel coronavirus.
What you need to know about Johnson & Johnson’s 2020 first-quarter earnings
Check out this infographic breakdown of the company’s first-quarter 2020 performance, with key highlights from its pharmaceutical, consumer and medical devices businesses.
6 impactful ways Johnson & Johnson is helping in the fight against COVID-19
From work on an investigational vaccine candidate to a $50 million commitment in support of healthcare workers on the very front lines of the crisis around the world, learn how the company has taken action to help respond to the pandemic.
“I have never seen a moment so rich in collaboration, ingenuity and acts of bravery": Johnson & Johnson announces it has identified a lead COVID-19 vaccine candidate
Chairman & CEO Alex Gorsky shares that the company could have the first batches of a COVID-19 vaccine available for emergency-use authorization in early 2021—a substantially accelerated time frame in comparison to the typical vaccine development process.
Johnson & Johnson announces a $50 million commitment to support frontline health workers battling COVID-19
The funds will be earmarked for assisting the doctors, nurses, midwives and community health workers who are working tirelessly to treat patients around the world during the novel coronavirus pandemic.
“I was on the front lines of the COVID-19 outbreak in Wuhan": A doctor shares his story
Dr. Dongchen Zhou was a practicing cardiologist in Hangzhou, Zhejiang Province, China, when he received a call to help volunteer at a hospital in Wuhan. In February 2020 he began to treat COVID-19 patients—and recounts for us what his journey was like.